IRCCS San Raffaele Roma
Quick facts
Marketed products
- Levodopa Benserazide Madopar · Neurology
Levodopa is converted to dopamine in the brain to replace deficient neurotransmitter levels, while benserazide inhibits peripheral conversion of levodopa to prevent side effects. - Levodopa Benserazide Teva Italia · Neurology
Levodopa is converted to dopamine in the brain to replace deficient neurotransmitter levels, while benserazide inhibits peripheral conversion of levodopa to prevent side effects.
Phase 2 pipeline
- anti-CGRP monoclonal antibodies
- combination of sumatriptan and naproxen
- ditan · Other
- gepants · Other
- hydrolyzed guar gum
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about IRCCS San Raffaele Roma
What are IRCCS San Raffaele Roma's marketed drugs?
Top marketed products include Levodopa Benserazide Madopar, Levodopa Benserazide Teva Italia.
Related
- Levodopa Benserazide Madopar · Neurology
- Levodopa Benserazide Teva Italia · Neurology
- Sector hub: All tracked pharma companies